Tech Company Inital Public Offerings
AcelRx Pharmaceuticals IPO
On 2/11/2011, AcelRx Pharmaceuticals became a public company.
Transaction Overview
Company Name
Announced On
2/11/2011
Transaction Type
IPO
Amount
$40,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
351 Galveston Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
AcelRx Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the conceptualization, research, development, and commercialization of novel treatments for the management of painful conditions where currently available treatments are not optimal.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vincent Angotti
Chief Financial Officer
Raffi Asadorian
Chief Medical Officer
Pamela Palmer
VP - Bus. Development
Larry Hamel
VP - Engineering
Badri Dasu
Browse more venture capital transactions:
Prev: 2/11/2011: Chimerix venture capital transaction
Next: 2/11/2011: One Kings Lane venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs